Clinical Trials

Showing trials with last updates posted in 2016.

NCT01209130 | COMPLETED | PHASE1
91 participants

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2016-11-02
Start Date:
2010-10-31
Completion:
2015-03-31
Conditions
  • Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page